| Serial Number | 79327653 |
| Word Mark | CANIFERON |
| Filing Date | Thursday, September 16, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 31, 2023 |
| Registration Number | 6966132 |
| Registration Date | Tuesday, January 31, 2023 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 15, 2022 |
| Certificate of Correction for Registration | In the statement, " International Class 5 " is corrected per the public note dated 4/17/2025 |
| Goods and Services | [ Pharmaceuticals, medical and veterinary preparations for use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; pharmaceutical, medical and veterinary preparations for prevention, diagnosis and treatment of skin diseases; pharmaceutical, medical and veterinary preparations for dermatitis; pharmaceutical, medical and veterinary preparations for inflammatory diseases; medicines for veterinary purposes for use in the treatment of cancer, skin disorders and inflammatory diseases; pharmaceutical, medical and ] veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases, * pruritic conditions, coronavirus and allergies * [ and inflammatory diseases; pharmaceutical, medical and veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases and inflammatory diseases, for animals; pharmaceutical, medical and veterinary drugs for use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biological preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; biological reagents being pharmaceutical preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; biological tissue cultures for medical use; biochemical preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; anti-viral agents; diagnostic preparations for medical and veterinary purposes; clinical diagnostic reagents for medical and veterinary purposes; immunoassay reagents for medical use ] |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 10, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ILC Therapeutics Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | ILC Therapeutics Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | ILC Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, December 9, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, December 10, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 14, 2021 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, June 21, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, June 21, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 22, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, June 24, 2022 | REFUSAL PROCESSED BY MPU |
| Friday, June 24, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, July 19, 2022 | REFUSAL PROCESSED BY IB |
| Monday, October 3, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, October 3, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 4, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 11, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 26, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 15, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 15, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 13, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, January 31, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 31, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Sunday, April 30, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, May 5, 2023 | FINAL DISPOSITION PROCESSED |
| Friday, May 5, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, May 30, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, October 11, 2024 | LIMITATION OF GOODS RECEIVED FROM IB |
| Thursday, April 24, 2025 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, April 24, 2025 | CORRECTION UNDER SECTION 7 - PROCESSED |
| Thursday, May 1, 2025 | LIMITATION FROM THE IB EXAMINED AND ENTERED |
| Tuesday, May 13, 2025 | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED |
| Friday, November 21, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |